Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Vistagen's PALISADE Phase 3 program for fasedienol, a novel intranasal treatment for social anxiety disorder, progresses with multiple trials on track for top-line results in 2025.
VistaGen Therapeutics is progressing with Phase 3 clinical trials for fasedienol, a drug candidate for Social Anxiety Disorder (SAD).
Vistagen is progressing with its PALISADE Phase 3 program for fasedienol, targeting the acute treatment of social anxiety disorder (SAD).